Search research articles
Contact Us
Filters
Showing results (101-110 of 108) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 108 results.
JCO Oncology Practice
|
August 10, 2021
Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non-Safety-Net Centers
Julia R Trosman, Christine B Weldon, Bruce D Rapkin, et al.
Journal of Graduate Medical Education
|
August 22, 2017
Results of a Flipped Classroom Teaching Approach in Anesthesiology Residents
Susan M Martinelli, Fei Chen, Amy N DiLorenzo, et al.
European Journal of Nutrition
|
October 27, 2021
Individual participant data (IPD)-level meta-analysis of randomised controlled trials to estimate the vitamin D dietary requirements in dark-skinned individuals resident at high latitude
Kevin D Cashman, Mairead E Kiely, Rikke Andersen, et al.
Nature Communications
|
March 28, 2024
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Nature Communications
|
May 10, 2024
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer
Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, et al.
JAMA Oncology
|
July 10, 2020
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
Milan Radovich, Guanglong Jiang, Bradley A Hancock, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 108) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 108 results.
JCO Oncology Practice
|
August 10, 2021
Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non-Safety-Net Centers
Julia R Trosman, Christine B Weldon, Bruce D Rapkin, et al.
Journal of Graduate Medical Education
|
August 22, 2017
Results of a Flipped Classroom Teaching Approach in Anesthesiology Residents
Susan M Martinelli, Fei Chen, Amy N DiLorenzo, et al.
European Journal of Nutrition
|
October 27, 2021
Individual participant data (IPD)-level meta-analysis of randomised controlled trials to estimate the vitamin D dietary requirements in dark-skinned individuals resident at high latitude
Kevin D Cashman, Mairead E Kiely, Rikke Andersen, et al.
Nature Communications
|
March 28, 2024
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Nature Communications
|
May 10, 2024
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N Donahue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer
Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, et al.
JAMA Oncology
|
July 10, 2020
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
Milan Radovich, Guanglong Jiang, Bradley A Hancock, et al.
Page
of 11